M A Judson

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi Two year prognosis of sarcoidosis: the ACCESS experience
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA
    Sarcoidosis Vasc Diffuse Lung Dis 20:204-11. 2003
  2. ncbi The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, USA
    Respirology 13:97-102. 2008
  3. ncbi Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC, USA
    Eur Respir J 31:1189-96. 2008
  4. ncbi The diagnosis of sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, CSB 812, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29466, USA
    Clin Chest Med 29:415-27, viii. 2008
  5. ncbi A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI)
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, CSB 812, 96 Jonathan Lucas Street, Charleston, SC 29425, United States
    Med Hypotheses 68:1080-7. 2007
  6. ncbi Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 135:1358-9. 2009
  7. ncbi The diagnostic pathway to sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
    Chest 123:406-12. 2003
  8. ncbi The management of sarcoidosis by the primary care physician
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA
    Am J Med 120:403-7. 2007
  9. ncbi Extrapulmonary sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA
    Semin Respir Crit Care Med 28:83-101. 2007
  10. ncbi Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Semin Respir Crit Care Med 28:75-82. 2007

Detail Information

Publications61

  1. ncbi Two year prognosis of sarcoidosis: the ACCESS experience
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA
    Sarcoidosis Vasc Diffuse Lung Dis 20:204-11. 2003
    ..Several factors associated with improved or worse outcome over two years were identified...
  2. ncbi The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, USA
    Respirology 13:97-102. 2008
    ..In particular, the study sought to determine whether the CXR changes were a reliable indicator of disease exacerbation...
  3. ncbi Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC, USA
    Eur Respir J 31:1189-96. 2008
    ..Infliximab may be beneficial compared with placebo in the treatment of extrapulmonary sarcoidosis in patients already receiving corticosteroids, as assessed by the severity tool described in the present study...
  4. ncbi The diagnosis of sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, CSB 812, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29466, USA
    Clin Chest Med 29:415-27, viii. 2008
    ..The end result of this diagnostic evaluation for sarcoidosis is neither a definitive diagnosis nor an exclusion of the diagnosis, but rather a statistical likelihood of the disease...
  5. ncbi A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI)
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, CSB 812, 96 Jonathan Lucas Street, Charleston, SC 29425, United States
    Med Hypotheses 68:1080-7. 2007
    ..Although this instrument is presently not validated, it is hoped that it will undergo study as it rationally accounts for several problems of previous assessment instruments...
  6. ncbi Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 135:1358-9. 2009
    ..We suspect that infliximab disrupted the T-helper (Th) type 1-Th2 lymphocyte balance such that Th2 cytokines were left relatively unopposed, promoting the development of ABPA...
  7. ncbi The diagnostic pathway to sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
    Chest 123:406-12. 2003
    ..To examine the time from the first physician visit to the diagnosis of sarcoidosis...
  8. ncbi The management of sarcoidosis by the primary care physician
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA
    Am J Med 120:403-7. 2007
    ..This article outlines the approach to the evaluation and treatment of sarcoidosis by primary care physicians...
  9. ncbi Extrapulmonary sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA
    Semin Respir Crit Care Med 28:83-101. 2007
    ..This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis...
  10. ncbi Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Semin Respir Crit Care Med 28:75-82. 2007
    ..Atypical presentations may result in a delay in diagnosis as well as unnecessary treatment or diagnostic testing. We discuss four patients with an unusual presentation of thoracic sarcoidosis seen at our Sarcoidosis Clinic...
  11. ncbi Bullous sarcoidosis: a report of three cases
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
    Chest 114:1474-8. 1998
    ..Additional clues are the presence of mediastinal adenopathy on a chest radiograph or a CT scan and a history consistent with extrapulmonary sarcoidosis...
  12. ncbi An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA
    Chest 115:1158-65. 1999
    ..This article describes the use of corticosteroids for pulmonary sarcoidosis in terms of the above six phases. The proposed dosing schedules are based on the natural history of the disease and the results from published treatment studies...
  13. ncbi Sarcoidosis: clinical presentation, diagnosis, and approach to treatment
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 335:26-33. 2008
    ..Sarcoidosis may remit spontaneously or remain stable. Therefore, therapy is not mandated for the disease. This report reviews the clinical presentation, diagnostic approach, and treatment of sarcoidosis...
  14. ncbi Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid
    M A Judson
    Division of Vascular and Interventional Radiology, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 120:316-7. 2001
    ..CT-guided direct intralesional transthoracic injection of dexamethasone resulted in resolution of the patient's symptoms and a dramatic reduction in the size of the mass within 2 months...
  15. ncbi Comparison of sarcoidosis phenotypes among affected African-American siblings
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine CSB 812, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 130:855-62. 2006
    ..To test the hypothesis that sibling pairs, who share genes and environmental exposures, might have similar phenotypic expressions of sarcoidosis beyond what would be expected by chance alone...
  16. ncbi Current pharmacotherapy of allergic bronchopulmonary aspergillosis
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, USA
    Expert Opin Pharmacother 2:1065-71. 2001
    ..Multiple asthmatic exacerbations in a patient with ABPA suggest that chronic steroid therapy should be used. Itraconazole appears useful as a steroid sparing agent...
  17. ncbi The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis
    Marc A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Sarcoidosis Vasc Diffuse Lung Dis 23:51-7. 2006
    ..Few patients can tolerate doses of greater than 100 mg/day. Thalidomide may have been corticosteroid-sparing in a subgroup of these patients...
  18. ncbi Chronic cutaneous lesions of sarcoidosis
    Richard M Marchell
    Department of Dermatology, Medical University of South Carolina, SC 29425, USA
    Clin Dermatol 25:295-302. 2007
    ..This article will review the epidemiology, diagnostic evaluation, and description of the various chronic skin lesions of sarcoidosis. Various images of these skin lesions will be demonstrated...
  19. ncbi Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature
    Meena Kalluri
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Am J Med Sci 334:441-3. 2007
    ..It has also been reported to be elevated in certain granulomatous conditions. We describe a patient with sarcoidosis and an elevated serum CA 125 level and review the medical literature on this topic...
  20. ncbi Treatment of sarcoidosis with infliximab
    John D Doty
    Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, 96 Jonathan Lucas St, Suite 812-CSB, PO Box 250623, Charleston, SC 29425, USA
    Chest 127:1064-71. 2005
    ..Infliximab appears to be steroid sparing. Patients receiving the drug should be screened for latent tuberculosis and lymphoproliferative disorders...
  21. ncbi Pleural effusions in a series of 181 outpatients with sarcoidosis
    John T Huggins
    Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, PO Box 250625, Charleston, SC 29425, USA
    Chest 129:1599-604. 2006
    ..We performed thoracic ultrasonography prospectively in consecutive outpatients with sarcoidosis to determine the frequency of PEs caused by sarcoidosis and to define their pleural fluid characteristics...
  22. ncbi Cutaneous sarcoidosis
    Richard M Marchell
    Department of Dermatology, Medical University of South Carolina, Charleston, SC 29425, USA
    Semin Respir Crit Care Med 31:442-51. 2010
    ..Tumor necrosis factor-alpha (TNF-alpha) antagonists such as infliximab may have a role in cutaneous sarcoidosis, especially in refractory cases that are resistant to the standard regimens...
  23. ncbi Ambrisentan for sarcoidosis associated pulmonary hypertension
    M A Judson
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, USA
    Sarcoidosis Vasc Diffuse Lung Dis 28:139-45. 2011
    ..Sarcoidosis associated pulmonary hypertension (SAPH) is associated with significant morbidity and mortality. There is a paucity of information concerning therapy for this condition...
  24. ncbi Endoscopic ultrasonography with fine-needle aspiration: an accurate and simple diagnostic modality for sarcoidosis
    G Mishra
    Digestive Disease Center, Medical University of South Carolina, Charleston, USA
    Endoscopy 31:377-82. 1999
    ..The present study is a descriptive, retrospective one using endoscopic ultrasound with fine-needle aspiration (EUS-FNA) of mediastinal lymph nodes in seven patients with sarcoidosis...
  25. ncbi Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen
    John D Doty
    Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina Charleston, SC 29425, USA
    Chest 124:2023-6. 2003
    ..CONCLUSION: Short-course cyclophosphamide appears to be a reasonable, steroid-sparing treatment option for patients with corticosteroid-refractory neurosarcoidosis...
  26. ncbi Clinical outcomes in sarcoidosis after cessation of infliximab treatment
    Efstratios Panselinas
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
    Respirology 14:522-8. 2009
    ..Infliximab appears to be efficacious for the treatment of recalcitrant forms of sarcoidosis. However, there are minimal data concerning the course of sarcoidosis once infliximab is discontinued...
  27. ncbi Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipient
    G P LeMense
    Division of Pulmonary Critical Care Medicine, Medical University of South Carolina, Charleston 29425
    Chest 106:1918-20. 1994
    ..Atypical mycobacteria have not been reported as the etiology of pulmonary nodules in a heart transplant recipient. We report a case of Mycobacterium scrofulaceum infection presenting as three discrete pulmonary nodules...
  28. ncbi Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations
    Brian P McKinzie
    Department of Pharmacy Services, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 339:1-4. 2010
    ..To the best of our knowledge, this is the shortest period of time over which the treatment of pulmonary sarcoidosis with corticosteroids has been assessed...
  29. ncbi Sarcoidosis presenting as bilateral vocal cord paralysis from bilateral compression of the recurrent laryngeal nerves from thoracic adenopathy
    Charles S Coffey
    Department of Otolaryngology Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    J Voice 23:631-4. 2009
    ..The presenting symptoms, clinical outcome, radiographs and laryngeal findings are discussed in detail. Sarcoidosis should therefore be added to the differential diagnosis of bilateral vocal fold paralysis...
  30. ncbi Vaginal involvement in a patient with sarcoidosis
    Sarah L Allen
    Department of Internal Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 137:455-6. 2010
    ..To our knowledge, this is the first reported case of this entity. An additional unusual finding was that her symptoms of gynecologic sarcoidosis occurred at the time of initial presentation of her pulmonary sarcoidosis...
  31. ncbi Staple metalloptysis after lung resection for mycetoma: a case report and a review of the literature
    Efstratios Panselinas
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina 29466, USA
    Am J Med Sci 336:365-7. 2008
    ..Although metalloptysis usually requires no therapy, it may indicate an active infectious process that requires appropriate therapy...
  32. ncbi Carpal tunnel syndrome in sarcoidosis
    G W Niemer
    Division of Rheumatology, Medical University of South Carolina, Charleston, USA
    Sarcoidosis Vasc Diffuse Lung Dis 18:296-300. 2001
    ..Our findings suggest that CTS is common in sarcoidosis...
  33. ncbi Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study
    Amanda C Schutt
    Medical University of South Carolina Medical Center and College of Pharmacy, Charleston, SC 29425, USA
    Respir Med 104:717-23. 2010
    ..The objective was to survey sarcoidosis experts concerning the treatment of pulmonary sarcoidosis and attempt to reach a consensus by these experts using a Delphi method...
  34. ncbi Pleural effusion caused by trapped lung
    Jay T Heidecker
    Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    South Med J 96:510-1. 2003
    ..Histologic examination of the lung, visceral and parietal pleura, and the fibrous adhesions all revealed noncaseating granulomas...
  35. ncbi A neutropenic patient with rapidly progressive lung lesion
    Darryl R Pauls
    Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29425, USA
    Chest 126:1364-7. 2004
  36. ncbi Trouble below the surface
    Charles M Wiener
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
    Am J Med 119:828-31. 2006
  37. ncbi Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?
    S M Wildi
    Digestive Disease Center, Medical University of South Carolina, Charleston, SC 29425, USA
    Thorax 59:794-9. 2004
    ..The reported sensitivity and specificity must be appreciated in the context of the difficult and often incomplete clinical diagnosis of sarcoidosis...
  38. ncbi Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature
    Wendy Bullington
    Department of Pharmacy Services and the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 333:290-2. 2007
    ..To report a case of valproic acid-induced eosinophilic pleural effusion and to review the existing literature...
  39. ncbi Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis
    Susan Garwood
    Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
    Chest 132:1298-304. 2007
    ..The purpose of this study was to assess the utility of EBUS-TBNA for pulmonary sarcoidosis...
  40. ncbi Health-related quality of life of persons with sarcoidosis
    Christopher E Cox
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, USA
    Chest 125:997-1004. 2004
    ..To describe the health-related quality of life (HRQL) and mental health of persons with sarcoidosis, as well as to assess physician-patient agreement about the presence of sarcoidosis symptoms...
  41. ncbi The spectrum of biopsy sites for the diagnosis of sarcoidosis
    Alvin S Teirstein
    Mount Sinai Medical Center, New York, NY 10029, USA
    Sarcoidosis Vasc Diffuse Lung Dis 22:139-46. 2005
    ..Clinicians must decide which site offers the best chance of achieving a diagnostic biopsy with the least patient risk and discomfort...
  42. ncbi Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
    Robert P Baughman
    University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
    Am J Respir Crit Care Med 174:795-802. 2006
    ..Evidence suggests that tumor necrosis factor (TNF)-alpha plays an important role in the pathophysiology of sarcoidosis...
  43. ncbi Thalidomide for chronic sarcoidosis
    Robert P Baughman
    Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA
    Chest 122:227-32. 2002
    ..Lupus pernio is a skin manifestation of sarcoidosis that does not remit spontaneously, and was used as a marker of efficacy of thalidomide for sarcoidosis...
  44. ncbi Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems
    Robert P Baughman
    University of Cincinnati Medical Center, Cincinnati, Ohio 45267, USA
    Am J Clin Dermatol 9:155-61. 2008
    ..Facial lesions including lupus pernio are often a form of chronic cutaneous sarcoidosis...
  45. ncbi The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life
    Christopher E Cox
    Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Respir Crit Care Med 168:323-9. 2003
    ..The SHQ alone was sensitive to differences in HRQL based on the number of involved organ systems. In conclusion, we have developed a self-completed HRQL questionnaire for U.S. patients with sarcoidosis...
  46. ncbi Use of fluticasone in acute symptomatic pulmonary sarcoidosis
    Robert P Baughman
    Department of Internal Medicine, University of Cincinnati Medical Center, OH 45267 0565, USA
    Sarcoidosis Vasc Diffuse Lung Dis 19:198-204. 2002
    ..Inhaled corticosteroids have been used with variable success in sarcoidosis. The role of the inhaled corticosteroid fluticasone in symptomatic pulmonary patients was studied...
  47. ncbi A case control etiologic study of sarcoidosis: environmental and occupational risk factors
    Lee S Newman
    National Jewish Medical and Research Center and Univresity of Colorado Health Scienes Center, Denver, CO 80206, USA
    Am J Respir Crit Care Med 170:1324-30. 2004
    ..65, CI 0.51-0.82). The study did not identify a single, predominant cause of sarcoidosis. We identified several exposures associated with sarcoidosis risk, including insecticides, agricultural employment, and microbial bioaerosols...
  48. ncbi Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics
    Gloria E Westney
    Pulmonary and Critical Care Section, Department of Medicine, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA
    Clin Chest Med 27:453-62, vi. 2006
    ..The influences of genetics and socioeconomic status on the development and phenotypic expression of sarcoidosis will be better understood as the mechanisms of disease development are uncovered...
  49. ncbi Pulmonary and psychosocial findings at enrollment in the ACCESS study
    Henry Yeager
    Pulmonary, Critical Care, and Sleep Medicine, Georgetown University Medical Center, Washington, DC 20057, USA
    Sarcoidosis Vasc Diffuse Lung Dis 22:147-53. 2005
    ..To assess lung involvement and the association of demographic and psychosocial factors with respiratory health in 736 persons with sarcoidosis at enrollment in A Case Control Etiologic Study of Sarcoidosis (ACCESS)...
  50. ncbi Relationship of environmental exposures to the clinical phenotype of sarcoidosis
    Mary Elizabeth Kreider
    Division of Pulmonary and Critical Care, University of Pennsylvania School of Medicine, 826 Gates Building, 3400 Spruce St, Philadelphia, PA 19104, USA
    Chest 128:207-15. 2005
    ..We examined the relationship between environmental and occupational exposures, and the clinical phenotype of sarcoidosis...
  51. ncbi A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study
    Benjamin A Rybicki
    Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, MI 48202, USA
    Sarcoidosis Vasc Diffuse Lung Dis 22:115-22. 2005
    ..In the United States of America, African Americans have a higher sarcoidosis incidence and suffer greater morbidity than Caucasians...
  52. ncbi A new tool to assess sarcoidosis severity
    Yasmine S Wasfi
    Pulmonary, Allergy, and Critcal Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Chest 129:1234-45. 2006
    ..This preliminary tool has potential applicability in the assessment of disease severity in sarcoidosis research...
  53. ncbi Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granuloma
    Marc A Judson
    Chest 122:399-400. 2002
  54. ncbi The etiologic agent of sarcoidosis: what if there isn't one?
    Marc A Judson
    Chest 124:6-8. 2003
  55. ncbi Quality of life evaluation in sarcoidosis: current status and future directions
    David E Victorson
    Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA
    Curr Opin Pulm Med 14:470-7. 2008
    ..To describe the current state of knowledge concerning health-related quality of life research in sarcoidosis and suggest new approaches that could be explored...
  56. ncbi Bird-years as well as pack-years
    Marc A Judson
    Chest 125:353-4. 2004
  57. ncbi The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis
    Mark T Wagner
    Sarcoidosis Vasc Diffuse Lung Dis 22:235. 2005
  58. ncbi Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS)
    Juliana Barnard
    Division of Environmental and Occupational Health Sciences, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
    J Occup Environ Med 47:226-34. 2005
    ..To determine whether specific occupations and industries may be associated with sarcoidosis...
  59. ncbi Cardiac sarcoidosis: there is no instant replay
    Marc A Judson
    Chest 128:3-6. 2005
  60. ncbi Sarcoidosis
    Christopher E Cox
    Department of Medicine, Duke University Medical Center, Box 3221, Room 275, MSRB, Research Drive, Durham, NC 27710, USA
    Med Clin North Am 89:817-28. 2005
    ..Improving access to care and addressing other disparities in health care may help to bridge the gap in health outcomes observed between patients...
  61. ncbi Organizing pneumonia
    Fotis Drakopanagiotakis
    Third Pulmonary Department, Sismanoglio General Hospital, Athens, Greece
    Am J Med Sci 335:34-9. 2008
    ..Relapses occur frequently, usually when treatment is withdrawn or tapered. The prognosis is good in most of the cases of COP, whereas in SOP it is dependent on the underlying cause...